This photo provided by Seattle Genetics Inc., shows the breast cancer drug Tukysa, developed by Seattle Genetics. U.S. regulators on Thursday, April 14, 2020, approved the new drug for an aggressive type of breast cancer that’s spread in the body, including into the brain, where it’s especially tough to treat. (Seattle Genetics via AP)
Featured Photo Galleries
